http://archive.fast-edgar.com/20260908/AI22822FZZ2RR9ZA22ZC2ZYJNRJR4Z22Z28G
Filed on: September 8, 2026
Registration Statement No. 333-285508Filed Pursuant to Rule 424(b)(5)
The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement is not an offer to sell these securities and is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.
Preliminary Prospectus Supplement, subject to completion, dated September 8, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of September 2026
Commission File Number: 001-42013
Superx Ai Technology Limited
(Translation of registrant’s name into English)
30 Pasir Panjang Road
#06-31, Mapletree Business City
Singapore 117440
(Address of principal... (continue reading...)
Filed Pursuant to Rule 424(b)(3)Registration No. 333-279329
Prospectus Supplement No. 31
(to prospectus dated June 5, 2024)
44,382 Shares of Common Stock
This prospectus supplement amends and supplements the prospectus of Longevity Health Holdings, Inc. (“we,” “us,” or “our”) dated June 5, 2024 (as supplemented or amended from time to time, the “Prospectus”), which forms a part of our Registration... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K GENERAL ELECTRIC CO For: Sep 08
-
Form 15-12G LEGGETT & PLATT INC
-
Form 6-K Clearmind Medicine Inc. For: Sep 08
-
Form 497K Tidal Trust II
-
Form 4 Pyxis Oncology, Inc. For: Sep 04 Filed by: Civik Thomas
-
Form 8-K GROUP 1 AUTOMOTIVE INC For: Sep 08
-
Form 8-K IonQ, Inc. For: Sep 08
-
Form SCHEDULE 13G/A TPG Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G/A AAON, INC. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form SCHEDULE 13G Zenas BioPharma, Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
-
Form 8-K Pyxis Oncology, Inc. For: Sep 03
-
Form D 1789 Capital Fund II-B,
-
Form 8-K NABORS INDUSTRIES LTD For: Sep 08
-
Form 8-K Philip Morris Internatio For: Sep 08
-
Form 10-Q enGene Therapeutics Inc. For: Jul 31
-
Form D 1789 US Feeder II-A, LP
-
Form 4 SCHMID Group N.V. For: May 23 Filed by: Speth Ralf
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Greenberg Aaron Samuel
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Furman Carly Lisanne
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Sever Michal
-
Form 4 Nayax Ltd. For: Sep 04 Filed by: Manor Sagit
-
Form 4 ZIM Integrated Shipping For: Sep 04 Filed by: Meyer-Gloeckner Birger Johannes
-
Form N-CSRS ABERDEEN INDIA FUND, For: Jun 30
-
Form 6-K ZTO Express (Cayman) For: Sep 08
-
Form 8-K enGene Therapeutics Inc. For: Sep 08
-
Form 6-K Super Group (SGHC) Ltd For: Sep 08
-
Form N-CSRS abrdn Emerging Markets For: Jun 30
-
Form 6-K Waterdrop Inc. For: Sep 08
-
Form 8-K UNITED COMMUNITY BANKS For: Sep 08
-
Form 8-K Soluna Holdings, Inc For: Sep 08
-
Form 6-K XCHG Ltd For: Sep 07
-
Form 6-K Brainsway Ltd. For: Sep 08
-
Form D 1789 Capital Fund II-A,
-
Form 144 Nayax Ltd. Filed by: Manor Sagit
-
Form 6-K Hafnia Ltd For: Sep 08
-
Form 3 CHECK POINT SOFTWARE For: Sep 02 Filed by: Tietz Yoram
-
Form N-MFP3 MoA Funds Corp For: Aug 31
-
Form 8-K Rigetti Computing, Inc. For: Sep 04
-
Form 6-K COCA-COLA EUROPACIFIC For: Sep 08
-
Form 6-K Canaan Inc. For: Sep 08
-
Form SCHEDULE 13D/A 17 Education & Technolog Filed by: Liu Chang
-
Form 6-K HARMONY GOLD MINING CO For: Sep 07
-
Form 6-K Li Auto Inc. For: Sep 08
-
Form 8-K X4 Pharmaceuticals, Inc For: Sep 08
-
Form 6-K Vale S.A. For: Sep 30
-
Form 6-K Sibanye Stillwater Ltd For: Sep 08
-
Form 6-K BANCO BILBAO VIZCAYA For: Sep 07
-
Form 6-K IsoEnergy Ltd. For: Sep 08
-
Form 6-K Pulsenmore Ltd. For: Sep 08
-
Form 4 Jianpu Technology Inc. For: Sep 04 Filed by: Zhang Xiaoyan (XY)

